19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

Cancer Research

Volumn 72, Issue 7, 2012, Pages 1795-1803

  Stevens, Kristen N ^a   Fredericksen, Zachary ^a   Vachon, Celine M ^a   Wang, Xianshu ^a   Margolin, Sara ^b   Lindblom, Annika ^b   Nevanlinna, Heli ^d   Greco, Dario ^d   Aittomak̈i, Kristiina ^e   Blomqvist, Carl ^d   Chang Claude, Jenny ^f   Vrieling, Alina ^f   Flesch Janys, Dieter ⁱ   Sinn, Hans Peter ^g   Wang Gohrke, Shan ^j   Nickels, Stefan ^f   Brauch, Hiltrud ^k,l   Ko, Yon Dschun ^m   Fischer, Hans Peter ⁿ   Schmutzler, Rita K ^o   Meindl, Alfons ^p   Bartram, Claus R ^h   Schott, Sarah ^g   Engel, Christoph ^q   Godwin, Andrew K ^r   Weaver, JoEllen ^t   Pathak, Harsh B ^r   Sharma, Priyanka ^s   Brenner, Hermann ^f   Mul̈ler, Heiko ^f   Arndt, Volker ^f   Stegmaier, Christa ^u   Miron, Penelope ^v   Yannoukakos, Drakoulis ^w   Stavropoulou, Alexandra ^w   Fountzilas, George ^y   Gogas, Helen J ^x   Swann, Ruth ^z   Dwek, Miriam ^z   Perkins, Annie ^z   Milne, Roger L ^ad   Benit́ez, Javier ^ad   Zamora, Mariá Pilar ^ad   Peŕez, José Ignacio Arias ^ae   Bojesen, Stig E ^af   Nielsen, Sune F ^af   Nordestgaard, Brøge G ^af   Flyger, Henrik ^af   Gueńel, Pascal ^ag,ah   Truong, Theŕeśe ^ag,ah   Menegaux, Florence ^ag,ah   Cordina Duverger, Emilie ^ag,ah   Burwinkel, Barbara ^f,g   Marme, Frederick ^g,h   Schneeweiss, Andreas ^g,h   Sohn, Christof ^g   Sawyer, Elinor ^aa   Tomlinson, Ian ^ai   Kerin, Michael J ^aj   Peto, Julian ^ab   Johnson, Nichola ^ac   Fletcher, Olivia ^ac   Dos Santos Silva, Isabel ^ab   Fasching, Peter A ^ak,al   Beckmann, Matthias W ^al   Hartmann, Arndt ^al   Ekici, Arif B ^am   Lophatananon, Artitaya ^an   Muir, Kenneth ^an   Puttawibul, Puttisak ^ao   Wiangnon, Surapon ^ap   Schmidt, Marjanka K ^aq   Broeks, Annegien ^aq   Braaf, Linde M ^aq   Rosenberg, Efraim H ^aq   Hopper, John L ^ar   Apicella, Carmel ^ar   Park, Daniel J ^ar   Southey, Melissa C ^ar   Swerdlow, Anthony J ^ac   Ashworth, Alan ^ac   Nicholas, Orr ^ac   Schoemaker, Minouk J ^ac   Anton Culver, Hoda ^au   Ziogas, Argyrios ^au   Bernstein, Leslie ^av   Dur, Christina Clarke ^aw   Shen, Chen Yang ^ax   Yu, Jyh Cherng ^ay   Hsu, Huan Ming ^ay   Hsiung, Chia Ni ^ax   Hamann, Ute ^f   Dun̈nebier, Thomas ^f   Rud̈iger, Thomas ^az   Ulmer, Hans Ulrich ^az   Pharoah, Paul P ^ba   Dunning, Alison M ^ba   Humphreys, Manjeet K ^ba   Wang, Qin ^ba   Cox, Angela ^bb   Cross, Simon S ^bb   Reed, Malcom W ^bb   Hall, Per ^c   Czene, Kamila ^c   Ambrosone, Christine B ^bc   Ademuyiwa, Foluso ^bc   Hwang, Helena ^bc   Eccles, Diana M ^bd   Garcia Closas, Montserrat ^ac   Figueroa, Jonine D ^be   Sherman, Mark E ^be   Lissowska, Jolanta ^bf   Devilee, Peter ^bg   Seynaeve, Caroline ^bh   Tollenaar, Rob A E M ^bg   Hooning, Maartje J ^bh   Andrulis, Irene L ^bi   Knight, Julia A ^bj   Glendon, Gord ^bk   Mulligan, Anna Marie ^bl   Winqvist, Robert ^bm   Pylkas̈, Katri ^bm   Jukkola Vuorinen, Arja ^bm   Grip, Mervi ^bm   John, Esther M ^aw   Miron, Alexander ^v   Alnsæ, Grethe Grenaker ^bn,bo   Kristensen, Vessela ^bn,bo   Brøresen Dale, Anne Lise ^bo   Giles, Graham G ^ar,as   Baglietto, Laura ^ar,as   McLean, Catriona A ^at   Severi, Gianluca ^ar,as   Kosel, Matthew L ^a   Pankratz, V S ^a   Slager, Susan ^a   Olson, Janet E ^a   Radice, Paolo ^bp,bq   Peterlongo, Paolo ^bp,bq   Manoukian, Siranoush ^br   Barile, Monica ^bs   Lambrechts, Diether ^bt,bu   Hatse, Sigrid ^bv   Dieudonne, Anne Sophie ^bv   Christiaens, Marie Rose ^bv   Chenevix Trench, Georgia ^bw   Beesley, Jonathan ^bw   Chen, Xiaoqing ^bw   Mannermaa, Arto ^bx   Kosma, Veli Matti ^bx   Hartikainen, Jaana M ^bx   Soini, Ylermi ^bx   Easton, Douglas F ^az,ba   Couch, Fergus J ^a   more..

^a MAYO CLINIC   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j UNIVERSITY OF ULM   (Germany)

^k DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^l UNIVERSITY OF TÜBINGEN   (Germany)

^m Johanniter Krankenhaus   (Germany)

ⁿ UNIVERSITY OF BONN   (Germany)

^o UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^p TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^q UNIVERSITY OF LEIPZIG   (Germany)

^r UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^t FOX CHASE CANCER CENTER   (United States)

^u SAARLAND CANCER REGISTRY   (Germany)

^v DANA FARBER CANCER INSTITUTE   (United States)

^w INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^x UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^y ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^z UNIVERSITY OF WESTMINSTER   (United Kingdom)

^aa KING'S COLLEGE LONDON   (United Kingdom)

^ab LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^ac INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ad HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^ae HOSPITAL MONTE NARANCO   (Spain)

^af GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^ag NATIONAL INSTITUTES OF HEALTH   (United States)

^ah UNIVERSITÉ PARIS SACLAY   (France)

^ai UNIVERSITY OF OXFORD   (United Kingdom)

^aj UNIVERSITY HOSPITAL GALWAY   (Ireland)

^ak UNIVERSITY OF CALIFORNIA   (United States)

^al UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^am UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^an UNIVERSITY OF WARWICK   (United Kingdom)

^ao PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^ap KHON KAEN UNIVERSITY   (Thailand)

^aq NETHERLANDS CANCER INSTITUTE   (Netherlands)

^ar UNIVERSITY OF MELBOURNE   (Australia)

^as CANCER EPIDEMIOLOGY CENTRE   (Australia)

^at ALFRED HOSPITAL   (Australia)

^au UNIVERSITY OF CALIFORNIA   (United States)

^av CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^aw CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^ax INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^ay TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^az STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^ba UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^bb UNIVERSITY OF SHEFFIELD   (United Kingdom)

^bc ROSWELL PARK CANCER INSTITUTE   (United States)

^bd UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^be NATIONAL CANCER INSTITUTE   (United States)

^bf INSTITUTE OF ONCOLOGY   (Poland)

^bg LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bh ERASMUS MEDICAL CENTER   (Netherlands)

^bi UNIVERSITY OF TORONTO   (Canada)

^bj UNIVERSITY OF TORONTO   (Canada)

^bk PRINCESS MARGARET HOSPITAL   (Canada)

^bl ST MICHAEL'S HOSPITAL   (Canada)

^bm UNIVERSITY OF OULU   (Finland)

^bn UNIVERSITY OF OSLO   (Norway)

^bo OSLO UNIVERSITY HOSPITAL   (Norway)

^bp IRCCS   (Italy)

^bq FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^br NATIONAL CANCER INSTITUTE   (Italy)

^bs EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^bt DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^bu UNIVERSITY OF LEUVEN   (Belgium)

^bv UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^bw QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^bx UNIVERSITY OF EASTERN FINLAND   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 19P; CHROMOSOME IDENTIFICATION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER;

EID: 84859375225     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3364     Document Type: Article

References (24)

1. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al.Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39:865-9. (Pubitemid 47014497)
2. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40:703-6. (Pubitemid 351748861)
3. Garcia-Closas M, Chanock S. Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 2008;14:8000-9.
4. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008;4:e1000054.
5. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41:579-84.
6. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010;42:504-7.
7. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41:585-90.
8. Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011;20:4693-706.
9. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010;42:885-92.
10. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011;20:3289-303.
11. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009;18:1131-9.
12. Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 2011;71:6240-9.
13. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010;42:880-4.
14. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011;103:250-63.
15. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363:1938-48.
16. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007;16:439-43. (Pubitemid 46548646)
17. Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, et al. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res 2008;14:8010-8.
18. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008;109:123-39. (Pubitemid 351538762)
19. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007;109:1721-8. (Pubitemid 46668532)
20. Irvin WJ Jr, Carey LA. What is triple-negative breast cancer? Eur J Cancer 2008;44:2799-805.
21. Feng L, Huang J, Chen J. MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev 2009;23:719-28.
22. Shao G, Patterson-Fortin J, Messick TE, Feng D, Shanbhag N, Wang Y, et al. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev 2009;23:740-54.
23. Wang B, Hurov K, Hofmann K, Elledge SJ. NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control. Genes Dev 2009;23:729-39.
24. Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, et al. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell 2003;12:1087-99. (Pubitemid 37487920)